Cornerstones Health Presents:

Best of UEGW & ACG 2020: IBD Clinical Trials

Live Interactive Webinars

An Update on IBD Pivotal Clinical Trials from the United European Gastroenterology Week (UEGW) 2020 & the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting

Cornerstones Health
   

Dear Colleague,

Cornerstones is pleased to invite you to participate in a live, interactive webinar that will present a top-line summary of the key IBD pivotal trails from the UEGW and ACG virtual conferences.

This program was developed by an international group of IBD experts. Together, they reviewed all IBD-related clinical trials presented at UEGW and ACG and collaborated with study authors to compile a condensed update on the best research and most clinically pertinent data. As a unique feature, the webinars will include presentations from several primary authors of key clinical trials. This in-depth update will provide you with valuable education to implement new understanding into your ulcerative colitis and Crohn’s disease practice.

The Best of UEGW & ACG IBD Clinical Trials Webinars will be facilitated by Drs. Marla Dubinsky and David Rubin. We are offering several different date options to accommodate your schedule. Please register today to secure your place in one of these special webinars.

Sincerely,

Marla C. Dubinsky, MD

Cornerstones Co-Founder

New York, NY

David T. Rubin, MD

Cornerstones Co-Founder

Chicago, IL

Wednesday • November 18, 2020

8:00pm - 9:30pm ET

Register Here

Tuesday • November 24, 2020

8:00pm - 9:30pm ET

Register Here

Tuesday • December 1, 2020

8:00pm - 9:30pm ET

Register Here

Course Topics

  • Landscape of Approved Therapies
  • Mechanism of Action of Approved and New Therapies
  • Novel Paradigms in the Treatment of IBD
  • Ultra-Proactive Therapeutic Drug Monitoring
  • Summary of Cell Trafficking, Cytokines, & JAKinibs Clinical Trials

Support

Support for this activity has been made possible through educational grants from:

  • Bristol Myers Squibb
  • Janssen Biotech, Inc. (administered by Janssen Scientific Affairs, LLC)
  • Takeda Pharmaceutical USA

Learning Objectives

After successful completion of this CME/CE activity, participating members of the IBD care team are expected to be better able to:

  • Incorporate advances in therapeutic options and understanding of biologics, small molecules, biosimilars, and non-medical therapies for the treatment of Crohn’s disease & ulcerative colitis.
  • Consider the implications for short-term outcomes in IBD based on clinical presentation and treatment strategy.
  • Collaborate with other members of the care team to individualize management for people living with IBD.

Target Audience

The Best of UEGW & ACG 2020 program is specifically designed for gastroenterologists, nurse practitioners, physician assistants, and fellows involved in the management of patients with inflammatory bowel disease.

Accreditation and Credit Designation

Cornerstones Health

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Cornerstones Health. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

American Academy of CME, Inc., designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

American Academy of CME, Inc., designates this educational activity for 1.5 ANCC contact hours (1.0 pharmacotherapeutic contact hours). California: Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.

Physician Assistants

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Course Directors & Webinar Presenters

Marla C. Dubinsky, MD

Cornerstones Co-Founder

Professor of Pediatrics and Medicine

Icahn School of Medicine

Chief, Pediatric Gastroenterology and Nutrition

Mount Sinai Kravis Children’s Hospital

Co-Director, IBD Preconception and Pregnancy Planning Clinic

Mount Sinai School of Medicine

New York, NY

David T. Rubin, MD

Cornerstones Co-Founder

The Joseph B. Kirsner Professor of Medicine

Chief, Section of Gastroenterology, Hepatology and Nutrition

Co-Director, Digestive Diseases Center

The University of Chicago Medicine

Chicago, IL

Webinar Presenters

Sushila Dalal, MD

Assistant Professor of Medicine

The University of Chicago Medicine Chicago, IL

Elizabeth Spencer, MD

Assistant Professor Pediatrics

Icahn School of Medicine at Mount Sinai Mount Sinai Kravis Children’s Hospital New York, NY

Clinical Trial Presenters

Silvio Danese, MD, PhD

Humanitas Research Hospital

Milan, Italy

Iris Dotan, MD

Tel Aviv University

Tel Aviv, Israel

Brian Feagan, MD, FRCPC

Alimentiv Research Institute, University of Western Ontario

London, ON, Canada

William Sandborn, MD

University of California San Diego School of Medicine

La Jolla, CA

Séverine Vermeire, MD, PhD

University Hospitals Leuven

Leuven, Belgium

Course Development Faculty

James Lindsay, PhD, FRCP

Professor of Inflammatory Bowel Disease

Consultant Gastroenterologist

Barts Health NHS Trust

Professor of Inflammatory Bowel Disease

Queen Mary University of London

London, UK

Peter Irving, MA, MD, FRCP

Consultant Gastroenterologist

Guy’s and St. Thomas’ NHS Foundation Trust

Honorary Reader

King’s College London

London, UK